The selective blockade of microglial CD14 activity suppresses pro-inflammatory cytokine production in response to pathological TDP-43, reinforcing its connection to ALS pathogenesis, similarly to TREM2. Here, CD14 is linked to amyotrophic lateral sclerosis.